{"id":"NCT00575588","sponsor":"AstraZeneca","briefTitle":"52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period","officialTitle":"A 52-Week International, Multi-centre, Randomized, Parallel-group, Double-blind, Active-controlled, Phase III Study With a 52-Week Extension Period to Evaluate the Safety and Efficacy of Saxagliptin in Combination With Metformin Compared With Sulphonylurea in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Metformin Therapy Alone.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12","primaryCompletion":"2009-08","completion":"2010-08","firstPosted":"2007-12-18","resultsPosted":"2010-09-06","lastUpdate":"2012-03-21"},"enrollment":891,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"Sulphonylurea","otherNames":[]},{"type":"DRUG","name":"Saxagliptin","otherNames":["Onglyza"]}],"arms":[{"label":"Saxagliptin","type":"EXPERIMENTAL"},{"label":"Glipizide","type":"EXPERIMENTAL"}],"summary":"Saxagliptin is a new investigational medication being developed for treatment of type 2 diabetes. This study is designed to assess the efficacy and tolerability of saxagliptin in addition to metformin and compare to sulphonylurea in addition with metformin.","primaryOutcome":{"measure":"Hemoglobin A1c (HbA1c) Change From Baseline to Week 52","timeFrame":"Baseline to 52 Weeks","effectByArm":[{"arm":"Saxagliptin + Metformin","deltaMin":7.46,"sd":0.045},{"arm":"Glipizide + Metformin","deltaMin":7.53,"sd":0.045}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":94,"countries":["Finland","Germany","Hungary","India","Netherlands","Norway","Russia","Slovakia","South Korea","United Kingdom","Vietnam"]},"refs":{"pmids":["25414932","24397584","23638466"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":54,"n":428},"commonTop":["Hypoglycaemia","Nasopharyngitis","Hypertension","Diarrhoea","Upper Respiratory Tract Infection"]}}